Thank you, Madam Chair.
Thank you for the presentations today. I know we have very little time.
I'm interested in pursuing the reference that was brought up earlier regarding counterfeit drugs and how we are, to the best of your knowledge, checking for counterfeit drugs to ensure that patients are getting the right drug in terms of the relationship to adverse drug reactions.
Mr. Fraser, would you comment?